Ophthalmic anti-infectives are anti-infectives contained in a product formulated especially to be instilled or applied in the eye or eyes. Ophthalmic anti-infectives include eyedrops, gels or ointments. Anti-infectives are drugs that can either kill an infectious agent or inhibit it from spreading. Anti-infectives include antibiotics and antibacterials, antifungals, antivirals and antiprotozoals.
This report aims to provide a comprehensive presentation of the global market for Anti-Infective Ophthalmic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-Infective Ophthalmic. This report contains market size and forecasts of Anti-Infective Ophthalmic in global, including the following market information:
Global Anti-Infective Ophthalmic Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Anti-Infective Ophthalmic Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Anti-Infective Ophthalmic companies in 2022 (%)
The global Anti-Infective Ophthalmic market was valued at US$ 1510.6 million in 2022 and is projected to reach US$ 1877.9 million by 2029, at a CAGR of 3.2% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Major manufacturers of anti-infective eye drugs include Novartis, Allergan, Valeant Pharmaceuticals, Santen Pharmaceutical, Lupin Pharmaceuticals, Apotex and Akorn.
We surveyed the Anti-Infective Ophthalmic manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anti-Infective Ophthalmic Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Anti-Infective Ophthalmic Market Segment Percentages, by Type, 2022 (%)
Eyedrops
Gels
Ointments
Other
Global Anti-Infective Ophthalmic Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Anti-Infective Ophthalmic Market Segment Percentages, by Application, 2022 (%)
Hospital
Retail Pharmacy
Others
Global Anti-Infective Ophthalmic Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Anti-Infective Ophthalmic Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anti-Infective Ophthalmic revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Anti-Infective Ophthalmic revenues share in global market, 2022 (%)
Key companies Anti-Infective Ophthalmic sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Anti-Infective Ophthalmic sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Alcon
AbbVie
Bausch Health
Santen Pharmaceutical
Lupin Pharmaceuticals
Apotex
Akorn
Johnson & Johnson
Thea pharmaceuticals
URSAPHARM
SIMILASAN
Jianfeng Group
Outline of Major Chapters:
Chapter 1: Introduces the definition of Anti-Infective Ophthalmic, market overview.
Chapter 2: Global Anti-Infective Ophthalmic market size in revenue and volume.
Chapter 3: Detailed analysis of Anti-Infective Ophthalmic manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Anti-Infective Ophthalmic in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Anti-Infective Ophthalmic capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Anti-Infective Ophthalmic Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Anti-Infective Ophthalmic Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anti-Infective Ophthalmic Overall Market Size
2.1 Global Anti-Infective Ophthalmic Market Size: 2022 VS 2029
2.2 Global Anti-Infective Ophthalmic Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Anti-Infective Ophthalmic Sales: 2018-2029
3 Company Landscape
3.1 Top Anti-Infective Ophthalmic Players in Global Market
3.2 Top Global Anti-Infective Ophthalmic Companies Ranked by Revenue
3.3 Global Anti-Infective Ophthalmic Revenue by Companies
3.4 Global Anti-Infective Ophthalmic Sales by Companies
3.5 Global Anti-Infective Ophthalmic Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Anti-Infective Ophthalmic Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Anti-Infective Ophthalmic Product Type
3.8 Tier 1, Tier 2 and Tier 3 Anti-Infective Ophthalmic Players in Global Market
3.8.1 List of Global Tier 1 Anti-Infective Ophthalmic Companies
3.8.2 List of Global Tier 2 and Tier 3 Anti-Infective Ophthalmic Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Anti-Infective Ophthalmic Market Size Markets, 2022 & 2029
4.1.2 Eyedrops
4.1.3 Gels
4.1.4 Ointments
4.1.5 Other
4.2 By Type - Global Anti-Infective Ophthalmic Revenue & Forecasts
4.2.1 By Type - Global Anti-Infective Ophthalmic Revenue, 2018-2023
4.2.2 By Type - Global Anti-Infective Ophthalmic Revenue, 2024-2029
4.2.3 By Type - Global Anti-Infective Ophthalmic Revenue Market Share, 2018-2029
4.3 By Type - Global Anti-Infective Ophthalmic Sales & Forecasts
4.3.1 By Type - Global Anti-Infective Ophthalmic Sales, 2018-2023
4.3.2 By Type - Global Anti-Infective Ophthalmic Sales, 2024-2029
4.3.3 By Type - Global Anti-Infective Ophthalmic Sales Market Share, 2018-2029
4.4 By Type - Global Anti-Infective Ophthalmic Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Anti-Infective Ophthalmic Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Retail Pharmacy
5.1.4 Others
5.2 By Application - Global Anti-Infective Ophthalmic Revenue & Forecasts
5.2.1 By Application - Global Anti-Infective Ophthalmic Revenue, 2018-2023
5.2.2 By Application - Global Anti-Infective Ophthalmic Revenue, 2024-2029
5.2.3 By Application - Global Anti-Infective Ophthalmic Revenue Market Share, 2018-2029
5.3 By Application - Global Anti-Infective Ophthalmic Sales & Forecasts
5.3.1 By Application - Global Anti-Infective Ophthalmic Sales, 2018-2023
5.3.2 By Application - Global Anti-Infective Ophthalmic Sales, 2024-2029
5.3.3 By Application - Global Anti-Infective Ophthalmic Sales Market Share, 2018-2029
5.4 By Application - Global Anti-Infective Ophthalmic Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Anti-Infective Ophthalmic Market Size, 2022 & 2029
6.2 By Region - Global Anti-Infective Ophthalmic Revenue & Forecasts
6.2.1 By Region - Global Anti-Infective Ophthalmic Revenue, 2018-2023
6.2.2 By Region - Global Anti-Infective Ophthalmic Revenue, 2024-2029
6.2.3 By Region - Global Anti-Infective Ophthalmic Revenue Market Share, 2018-2029
6.3 By Region - Global Anti-Infective Ophthalmic Sales & Forecasts
6.3.1 By Region - Global Anti-Infective Ophthalmic Sales, 2018-2023
6.3.2 By Region - Global Anti-Infective Ophthalmic Sales, 2024-2029
6.3.3 By Region - Global Anti-Infective Ophthalmic Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Anti-Infective Ophthalmic Revenue, 2018-2029
6.4.2 By Country - North America Anti-Infective Ophthalmic Sales, 2018-2029
6.4.3 US Anti-Infective Ophthalmic Market Size, 2018-2029
6.4.4 Canada Anti-Infective Ophthalmic Market Size, 2018-2029
6.4.5 Mexico Anti-Infective Ophthalmic Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Anti-Infective Ophthalmic Revenue, 2018-2029
6.5.2 By Country - Europe Anti-Infective Ophthalmic Sales, 2018-2029
6.5.3 Germany Anti-Infective Ophthalmic Market Size, 2018-2029
6.5.4 France Anti-Infective Ophthalmic Market Size, 2018-2029
6.5.5 U.K. Anti-Infective Ophthalmic Market Size, 2018-2029
6.5.6 Italy Anti-Infective Ophthalmic Market Size, 2018-2029
6.5.7 Russia Anti-Infective Ophthalmic Market Size, 2018-2029
6.5.8 Nordic Countries Anti-Infective Ophthalmic Market Size, 2018-2029
6.5.9 Benelux Anti-Infective Ophthalmic Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Anti-Infective Ophthalmic Revenue, 2018-2029
6.6.2 By Region - Asia Anti-Infective Ophthalmic Sales, 2018-2029
6.6.3 China Anti-Infective Ophthalmic Market Size, 2018-2029
6.6.4 Japan Anti-Infective Ophthalmic Market Size, 2018-2029
6.6.5 South Korea Anti-Infective Ophthalmic Market Size, 2018-2029
6.6.6 Southeast Asia Anti-Infective Ophthalmic Market Size, 2018-2029
6.6.7 India Anti-Infective Ophthalmic Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Anti-Infective Ophthalmic Revenue, 2018-2029
6.7.2 By Country - South America Anti-Infective Ophthalmic Sales, 2018-2029
6.7.3 Brazil Anti-Infective Ophthalmic Market Size, 2018-2029
6.7.4 Argentina Anti-Infective Ophthalmic Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Anti-Infective Ophthalmic Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Anti-Infective Ophthalmic Sales, 2018-2029
6.8.3 Turkey Anti-Infective Ophthalmic Market Size, 2018-2029
6.8.4 Israel Anti-Infective Ophthalmic Market Size, 2018-2029
6.8.5 Saudi Arabia Anti-Infective Ophthalmic Market Size, 2018-2029
6.8.6 UAE Anti-Infective Ophthalmic Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Alcon
7.1.1 Alcon Company Summary
7.1.2 Alcon Business Overview
7.1.3 Alcon Anti-Infective Ophthalmic Major Product Offerings
7.1.4 Alcon Anti-Infective Ophthalmic Sales and Revenue in Global (2018-2023)
7.1.5 Alcon Key News & Latest Developments
7.2 AbbVie
7.2.1 AbbVie Company Summary
7.2.2 AbbVie Business Overview
7.2.3 AbbVie Anti-Infective Ophthalmic Major Product Offerings
7.2.4 AbbVie Anti-Infective Ophthalmic Sales and Revenue in Global (2018-2023)
7.2.5 AbbVie Key News & Latest Developments
7.3 Bausch Health
7.3.1 Bausch Health Company Summary
7.3.2 Bausch Health Business Overview
7.3.3 Bausch Health Anti-Infective Ophthalmic Major Product Offerings
7.3.4 Bausch Health Anti-Infective Ophthalmic Sales and Revenue in Global (2018-2023)
7.3.5 Bausch Health Key News & Latest Developments
7.4 Santen Pharmaceutical
7.4.1 Santen Pharmaceutical Company Summary
7.4.2 Santen Pharmaceutical Business Overview
7.4.3 Santen Pharmaceutical Anti-Infective Ophthalmic Major Product Offerings
7.4.4 Santen Pharmaceutical Anti-Infective Ophthalmic Sales and Revenue in Global (2018-2023)
7.4.5 Santen Pharmaceutical Key News & Latest Developments
7.5 Lupin Pharmaceuticals
7.5.1 Lupin Pharmaceuticals Company Summary
7.5.2 Lupin Pharmaceuticals Business Overview
7.5.3 Lupin Pharmaceuticals Anti-Infective Ophthalmic Major Product Offerings
7.5.4 Lupin Pharmaceuticals Anti-Infective Ophthalmic Sales and Revenue in Global (2018-2023)
7.5.5 Lupin Pharmaceuticals Key News & Latest Developments
7.6 Apotex
7.6.1 Apotex Company Summary
7.6.2 Apotex Business Overview
7.6.3 Apotex Anti-Infective Ophthalmic Major Product Offerings
7.6.4 Apotex Anti-Infective Ophthalmic Sales and Revenue in Global (2018-2023)
7.6.5 Apotex Key News & Latest Developments
7.7 Akorn
7.7.1 Akorn Company Summary
7.7.2 Akorn Business Overview
7.7.3 Akorn Anti-Infective Ophthalmic Major Product Offerings
7.7.4 Akorn Anti-Infective Ophthalmic Sales and Revenue in Global (2018-2023)
7.7.5 Akorn Key News & Latest Developments
7.8 Johnson & Johnson
7.8.1 Johnson & Johnson Company Summary
7.8.2 Johnson & Johnson Business Overview
7.8.3 Johnson & Johnson Anti-Infective Ophthalmic Major Product Offerings
7.8.4 Johnson & Johnson Anti-Infective Ophthalmic Sales and Revenue in Global (2018-2023)
7.8.5 Johnson & Johnson Key News & Latest Developments
7.9 Thea pharmaceuticals
7.9.1 Thea pharmaceuticals Company Summary
7.9.2 Thea pharmaceuticals Business Overview
7.9.3 Thea pharmaceuticals Anti-Infective Ophthalmic Major Product Offerings
7.9.4 Thea pharmaceuticals Anti-Infective Ophthalmic Sales and Revenue in Global (2018-2023)
7.9.5 Thea pharmaceuticals Key News & Latest Developments
7.10 URSAPHARM
7.10.1 URSAPHARM Company Summary
7.10.2 URSAPHARM Business Overview
7.10.3 URSAPHARM Anti-Infective Ophthalmic Major Product Offerings
7.10.4 URSAPHARM Anti-Infective Ophthalmic Sales and Revenue in Global (2018-2023)
7.10.5 URSAPHARM Key News & Latest Developments
7.11 SIMILASAN
7.11.1 SIMILASAN Company Summary
7.11.2 SIMILASAN Anti-Infective Ophthalmic Business Overview
7.11.3 SIMILASAN Anti-Infective Ophthalmic Major Product Offerings
7.11.4 SIMILASAN Anti-Infective Ophthalmic Sales and Revenue in Global (2018-2023)
7.11.5 SIMILASAN Key News & Latest Developments
7.12 Jianfeng Group
7.12.1 Jianfeng Group Company Summary
7.12.2 Jianfeng Group Anti-Infective Ophthalmic Business Overview
7.12.3 Jianfeng Group Anti-Infective Ophthalmic Major Product Offerings
7.12.4 Jianfeng Group Anti-Infective Ophthalmic Sales and Revenue in Global (2018-2023)
7.12.5 Jianfeng Group Key News & Latest Developments
8 Global Anti-Infective Ophthalmic Production Capacity, Analysis
8.1 Global Anti-Infective Ophthalmic Production Capacity, 2018-2029
8.2 Anti-Infective Ophthalmic Production Capacity of Key Manufacturers in Global Market
8.3 Global Anti-Infective Ophthalmic Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Anti-Infective Ophthalmic Supply Chain Analysis
10.1 Anti-Infective Ophthalmic Industry Value Chain
10.2 Anti-Infective Ophthalmic Upstream Market
10.3 Anti-Infective Ophthalmic Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Anti-Infective Ophthalmic Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Anti-Infective Ophthalmic in Global Market
Table 2. Top Anti-Infective Ophthalmic Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Anti-Infective Ophthalmic Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Anti-Infective Ophthalmic Revenue Share by Companies, 2018-2023
Table 5. Global Anti-Infective Ophthalmic Sales by Companies, (K Units), 2018-2023
Table 6. Global Anti-Infective Ophthalmic Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Anti-Infective Ophthalmic Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Anti-Infective Ophthalmic Product Type
Table 9. List of Global Tier 1 Anti-Infective Ophthalmic Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anti-Infective Ophthalmic Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Anti-Infective Ophthalmic Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Anti-Infective Ophthalmic Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Anti-Infective Ophthalmic Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Anti-Infective Ophthalmic Sales (K Units), 2018-2023
Table 15. By Type - Global Anti-Infective Ophthalmic Sales (K Units), 2024-2029
Table 16. By Application ? Global Anti-Infective Ophthalmic Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Anti-Infective Ophthalmic Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Anti-Infective Ophthalmic Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Anti-Infective Ophthalmic Sales (K Units), 2018-2023
Table 20. By Application - Global Anti-Infective Ophthalmic Sales (K Units), 2024-2029
Table 21. By Region ? Global Anti-Infective Ophthalmic Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Anti-Infective Ophthalmic Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Anti-Infective Ophthalmic Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Anti-Infective Ophthalmic Sales (K Units), 2018-2023
Table 25. By Region - Global Anti-Infective Ophthalmic Sales (K Units), 2024-2029
Table 26. By Country - North America Anti-Infective Ophthalmic Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Anti-Infective Ophthalmic Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Anti-Infective Ophthalmic Sales, (K Units), 2018-2023
Table 29. By Country - North America Anti-Infective Ophthalmic Sales, (K Units), 2024-2029
Table 30. By Country - Europe Anti-Infective Ophthalmic Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Anti-Infective Ophthalmic Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Anti-Infective Ophthalmic Sales, (K Units), 2018-2023
Table 33. By Country - Europe Anti-Infective Ophthalmic Sales, (K Units), 2024-2029
Table 34. By Region - Asia Anti-Infective Ophthalmic Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Anti-Infective Ophthalmic Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Anti-Infective Ophthalmic Sales, (K Units), 2018-2023
Table 37. By Region - Asia Anti-Infective Ophthalmic Sales, (K Units), 2024-2029
Table 38. By Country - South America Anti-Infective Ophthalmic Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Anti-Infective Ophthalmic Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Anti-Infective Ophthalmic Sales, (K Units), 2018-2023
Table 41. By Country - South America Anti-Infective Ophthalmic Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Anti-Infective Ophthalmic Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Anti-Infective Ophthalmic Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Anti-Infective Ophthalmic Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Anti-Infective Ophthalmic Sales, (K Units), 2024-2029
Table 46. Alcon Company Summary
Table 47. Alcon Anti-Infective Ophthalmic Product Offerings
Table 48. Alcon Anti-Infective Ophthalmic Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Alcon Key News & Latest Developments
Table 50. AbbVie Company Summary
Table 51. AbbVie Anti-Infective Ophthalmic Product Offerings
Table 52. AbbVie Anti-Infective Ophthalmic Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. AbbVie Key News & Latest Developments
Table 54. Bausch Health Company Summary
Table 55. Bausch Health Anti-Infective Ophthalmic Product Offerings
Table 56. Bausch Health Anti-Infective Ophthalmic Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Bausch Health Key News & Latest Developments
Table 58. Santen Pharmaceutical Company Summary
Table 59. Santen Pharmaceutical Anti-Infective Ophthalmic Product Offerings
Table 60. Santen Pharmaceutical Anti-Infective Ophthalmic Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Santen Pharmaceutical Key News & Latest Developments
Table 62. Lupin Pharmaceuticals Company Summary
Table 63. Lupin Pharmaceuticals Anti-Infective Ophthalmic Product Offerings
Table 64. Lupin Pharmaceuticals Anti-Infective Ophthalmic Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Lupin Pharmaceuticals Key News & Latest Developments
Table 66. Apotex Company Summary
Table 67. Apotex Anti-Infective Ophthalmic Product Offerings
Table 68. Apotex Anti-Infective Ophthalmic Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. Apotex Key News & Latest Developments
Table 70. Akorn Company Summary
Table 71. Akorn Anti-Infective Ophthalmic Product Offerings
Table 72. Akorn Anti-Infective Ophthalmic Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Akorn Key News & Latest Developments
Table 74. Johnson & Johnson Company Summary
Table 75. Johnson & Johnson Anti-Infective Ophthalmic Product Offerings
Table 76. Johnson & Johnson Anti-Infective Ophthalmic Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. Johnson & Johnson Key News & Latest Developments
Table 78. Thea pharmaceuticals Company Summary
Table 79. Thea pharmaceuticals Anti-Infective Ophthalmic Product Offerings
Table 80. Thea pharmaceuticals Anti-Infective Ophthalmic Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 81. Thea pharmaceuticals Key News & Latest Developments
Table 82. URSAPHARM Company Summary
Table 83. URSAPHARM Anti-Infective Ophthalmic Product Offerings
Table 84. URSAPHARM Anti-Infective Ophthalmic Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 85. URSAPHARM Key News & Latest Developments
Table 86. SIMILASAN Company Summary
Table 87. SIMILASAN Anti-Infective Ophthalmic Product Offerings
Table 88. SIMILASAN Anti-Infective Ophthalmic Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 89. SIMILASAN Key News & Latest Developments
Table 90. Jianfeng Group Company Summary
Table 91. Jianfeng Group Anti-Infective Ophthalmic Product Offerings
Table 92. Jianfeng Group Anti-Infective Ophthalmic Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 93. Jianfeng Group Key News & Latest Developments
Table 94. Anti-Infective Ophthalmic Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 95. Global Anti-Infective Ophthalmic Capacity Market Share of Key Manufacturers, 2021-2023
Table 96. Global Anti-Infective Ophthalmic Production by Region, 2018-2023 (K Units)
Table 97. Global Anti-Infective Ophthalmic Production by Region, 2024-2029 (K Units)
Table 98. Anti-Infective Ophthalmic Market Opportunities & Trends in Global Market
Table 99. Anti-Infective Ophthalmic Market Drivers in Global Market
Table 100. Anti-Infective Ophthalmic Market Restraints in Global Market
Table 101. Anti-Infective Ophthalmic Raw Materials
Table 102. Anti-Infective Ophthalmic Raw Materials Suppliers in Global Market
Table 103. Typical Anti-Infective Ophthalmic Downstream
Table 104. Anti-Infective Ophthalmic Downstream Clients in Global Market
Table 105. Anti-Infective Ophthalmic Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Anti-Infective Ophthalmic Segment by Type in 2022
Figure 2. Anti-Infective Ophthalmic Segment by Application in 2022
Figure 3. Global Anti-Infective Ophthalmic Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Anti-Infective Ophthalmic Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Anti-Infective Ophthalmic Revenue, 2018-2029 (US$, Mn)
Figure 7. Anti-Infective Ophthalmic Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Anti-Infective Ophthalmic Revenue in 2022
Figure 9. By Type - Global Anti-Infective Ophthalmic Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Anti-Infective Ophthalmic Revenue Market Share, 2018-2029
Figure 11. By Type - Global Anti-Infective Ophthalmic Sales Market Share, 2018-2029
Figure 12. By Type - Global Anti-Infective Ophthalmic Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Anti-Infective Ophthalmic Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Anti-Infective Ophthalmic Revenue Market Share, 2018-2029
Figure 15. By Application - Global Anti-Infective Ophthalmic Sales Market Share, 2018-2029
Figure 16. By Application - Global Anti-Infective Ophthalmic Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Anti-Infective Ophthalmic Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Anti-Infective Ophthalmic Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Anti-Infective Ophthalmic Revenue Market Share, 2018-2029
Figure 20. By Region - Global Anti-Infective Ophthalmic Sales Market Share, 2018-2029
Figure 21. By Country - North America Anti-Infective Ophthalmic Revenue Market Share, 2018-2029
Figure 22. By Country - North America Anti-Infective Ophthalmic Sales Market Share, 2018-2029
Figure 23. US Anti-Infective Ophthalmic Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Anti-Infective Ophthalmic Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Anti-Infective Ophthalmic Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Anti-Infective Ophthalmic Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Anti-Infective Ophthalmic Sales Market Share, 2018-2029
Figure 28. Germany Anti-Infective Ophthalmic Revenue, (US$, Mn), 2018-2029
Figure 29. France Anti-Infective Ophthalmic Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Anti-Infective Ophthalmic Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Anti-Infective Ophthalmic Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Anti-Infective Ophthalmic Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Anti-Infective Ophthalmic Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Anti-Infective Ophthalmic Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Anti-Infective Ophthalmic Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Anti-Infective Ophthalmic Sales Market Share, 2018-2029
Figure 37. China Anti-Infective Ophthalmic Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Anti-Infective Ophthalmic Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Anti-Infective Ophthalmic Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Anti-Infective Ophthalmic Revenue, (US$, Mn), 2018-2029
Figure 41. India Anti-Infective Ophthalmic Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Anti-Infective Ophthalmic Revenue Market Share, 2018-2029
Figure 43. By Country - South America Anti-Infective Ophthalmic Sales Market Share, 2018-2029
Figure 44. Brazil Anti-Infective Ophthalmic Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Anti-Infective Ophthalmic Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Anti-Infective Ophthalmic Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Anti-Infective Ophthalmic Sales Market Share, 2018-2029
Figure 48. Turkey Anti-Infective Ophthalmic Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Anti-Infective Ophthalmic Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Anti-Infective Ophthalmic Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Anti-Infective Ophthalmic Revenue, (US$, Mn), 2018-2029
Figure 52. Global Anti-Infective Ophthalmic Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Anti-Infective Ophthalmic by Region, 2022 VS 2029
Figure 54. Anti-Infective Ophthalmic Industry Value Chain
Figure 55. Marketing Channels
